scorecardresearch
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
Ajanta Pharma Ltd
Ajanta Pharma Ltd

Ajanta Pharma Ltd (AJANTPHARM) Share Price

  • Sector: Pharmaceuticals (Mid Cap)
  • Volume: 103,899
Mar 10, 2025 15:56 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹2,522.25
₹-40.60 (-1.58%)
₹2509 Low
Today’s Performance
₹2616.9 High
₹1998.35 Low
52 Week’s Performance
₹3485 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -1.58%
  • 1 Week 3.20%
  • 1 Month -2.96%
  • 3 Months -10.69%
  • 6 Months -26.39%
  • 1 Year 19.99%
  • 3 Years 29.09%
  • 5 Years 22.07%

PEER COMPARISON

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

Jan 25, 2024 PURCHASE
SOCIETE GENERALE
  • Qty 125617
  • Average Price ₹2,195.50
Jan 25, 2024 PURCHASE
MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUND
  • Qty 47901
  • Average Price ₹2,195.50
Jan 25, 2024 Sell
BNP PARIBAS ARBITRAGE
  • Qty 50586
  • Average Price ₹2,195.50
Jan 25, 2024 PURCHASE
MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUND
  • Qty 2685
  • Average Price ₹2,195.50
Jan 25, 2024 Sell
BNP PARIBAS ARBITRAGE
  • Qty 125617
  • Average Price ₹2,195.50
Dec 22, 2022 PURCHASE
ABS DIRECT EQUITY FUND LLC - INDIA SERIES 1
  • Qty 21356
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
FRANKLIN TEMPLETON INVESTMENT FUNDS - TEMPLETON ASIAN SMALLER COMPANIES FUND
  • Qty 343522
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC - WHITE OAK CAPITAL PARTNERS PTE LTD.
  • Qty 29086
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
ASHOKA INDIA EQUITY INVESTMENT TRUST PLC
  • Qty 24931
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
ABU DHABI INVESTMENT AUTHORITY - WAY
  • Qty 173683
  • Average Price ₹1,160.10
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of 10 crore.
Dec 22, 2022 PURCHASE
ICICI PRUDENTIAL MUTUAL FUND
  • Qty 1086110
  • Average Price ₹1,160.10
Dec 22, 2022 PURCHASE
NIPPON INDIA MUTUAL FUND
  • Qty 715450
  • Average Price ₹1,160.10
Dec 22, 2022 Sell
AAYUSH AGRAWAL TRUST
  • Qty 3853959
  • Average Price ₹1,160.10
Dec 22, 2022 Sell
RAVI AGRAWAL TRUST
  • Qty 1638887
  • Average Price ₹1,160.10
Apr 18, 2019 Sell
KOTAK MAHINDRA (INTERNATIONAL) LTD
  • Qty 505977
  • Average Price ₹1,033.00
Jul 11, 2017 Sell
GANGA EXPORTS
  • Qty 2485000
  • Average Price ₹1,500.11
Jul 11, 2017 PURCHASE
SBI MUTUAL FUND
  • Qty 1357000
  • Average Price ₹1,500.00
Jul 11, 2017 Sell
GANGA EXPORTS
  • Qty 2485000
  • Average Price ₹1,500.11
Jul 11, 2017 PURCHASE
SBI MUTUAL FUND
  • Qty 1357000
  • Average Price ₹1,500.00
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Ajanta Pharma Ltd share price previously?
Ajanta Pharma Ltd share price was down by -1.58% from the previous closing price of ₹2,562.85.
Who are peers of Ajanta Pharma Ltd?
The peers of Ajanta Pharma Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Mankind Pharma Ltd, Lupin Ltd,
Who is/are the promoter/promoters of Ajanta Pharma Ltd?
The promotor/promotors of Ajanta Pharma Ltd are Mannalal B Agrawal, Madhusudan B Agrawal, Yogesh Agrawal, Chandrakanth M Khetan, Gaurang Shah, Rajesh M Agrawal, K H Viswanathan, Prabhakar Dalal, Anjana Grewal, David Rasquinha, Medha Joshi, Simi Thapar, Rajesh Shashikant Dalal.
What has been 52-week high of Ajanta Pharma Ltd stocks?
The highest price of Ajanta Pharma Ltd stock is ₹3,485.00 in the last 52-week.
What is the share price of Ajanta Pharma Ltd (AJANTPHARM) today on NSE?
As on Mar 10, 2025, Ajanta Pharma Ltd (AJANTPHARM)’s share price on NSE is Rs 2522.25
What is the market cap of Ajanta Pharma Ltd (AJANTPHARM?)
The current market capitalisation of Ajanta Pharma Ltd (AJANTPHARM) is 32,013.10 crores
What is Ajanta Pharma Ltd Share symbol?
The symbol of Ajanta Pharma Ltd is AJANTPHARM.
What is the PE ratio of Ajanta Pharma Ltd (AJANTPHARM)?
The current PE ratio of Ajanta Pharma Ltd (AJANTPHARM) is 35.67.
What is the PB ratio of Ajanta Pharma Ltd (AJANTPHARM)?
The current PB ratio of Ajanta Pharma Ltd (AJANTPHARM) is 8.71.
Today’s High & Low share prices of Ajanta Pharma Ltd (AJANTPHARM) on NSE?
Today, the share price of Ajanta Pharma Ltd (AJANTPHARM) on NSE touched a high of Rs 2616.9 and a low of Rs 2509
What price did Ajanta Pharma Ltd (AJANTPHARM) shares open on the NSE today?
On NSE, the share price of Ajanta Pharma Ltd (AJANTPHARM) opened at Rs 2560.05
What is the 52-week high of Ajanta Pharma Ltd (AJANTPHARM)?
The 52-week high price of Ajanta Pharma Ltd (AJANTPHARM) is Rs 3485
What is the 52-week low of Ajanta Pharma Ltd (AJANTPHARM) ?
The 52-week low price of Ajanta Pharma Ltd (AJANTPHARM) is Rs 1998.35
Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement